BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8692120)

  • 1. [Ex vivo increase in hematopoietic progenitor cells for clinical use].
    Arseniev L; Battmer K; Stucki A; Südmeyer I; Kadar JG; Martin M; Link H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():50-9. PubMed ID: 8692120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells].
    Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP
    Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of FLT3 ligand in progenitor and primitive hematopoietic cell expansion.
    Poloni A; Douay L; Giarratana MC; Kobari L; Gorin NC; Olivieri A; Leoni P
    Boll Soc Ital Biol Sper; 1997; 73(3-4):55-62. PubMed ID: 9540233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical-scale expansion of mobilized CD 34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.
    Ivanovic Z; Duchez P; Dazey B; Hermitte F; Lamrissi-Garcia I; Mazurier F; Praloran V; Reiffers J; Vezon G; Boiron JM
    Transfusion; 2006 Jan; 46(1):126-31. PubMed ID: 16398741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous cord blood transplantation of ex vivo expanded together with non-expanded cells for high risk leukemia.
    Kögler G; Nürnberger W; Fischer J; Niehues T; Somville T; Göbel U; Wernet P
    Bone Marrow Transplant; 1999 Aug; 24(4):397-403. PubMed ID: 10467329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonogenic capacity and ex vivo expansion potential of umbilical cord blood progenitor cells are not impaired by cryopreservation.
    Almici C; Carlo-Stella C; Wagner JE; Mangoni L; Garau D; Re A; Giachetti R; Cesana C; Rizzoli V
    Bone Marrow Transplant; 1997 Jun; 19(11):1079-84. PubMed ID: 9193749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood CD34+ cells: method of purification and ex vivo expansion.
    Bohbot A; Feugeas O; Cuillerot JM; Grosse A; Rusciani I; Faradji A; Oberling F
    Nouv Rev Fr Hematol (1978); 1995; 37(6):359-65. PubMed ID: 8907632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.
    Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M
    Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different thawing methods, growth factor combinations and media on the ex vivo expansion of umbilical cord blood primitive and committed progenitors.
    Kögler G; Callejas J; Sorg RV; Fischer J; Migliaccio AR; Wernet P
    Bone Marrow Transplant; 1998 Feb; 21(3):233-41. PubMed ID: 9489645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia.
    Andrews RG; Briddell RA; Hill R; Gough M; McNiece IK
    Stem Cells; 1999; 17(4):210-8. PubMed ID: 10437984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.
    Brugger W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    N Engl J Med; 1995 Aug; 333(5):283-7. PubMed ID: 7541111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.